Bridgeway Capital Management, LLC Impel Pharmaceuticals Inc Transaction History

Bridgeway Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.96 - $4.1 $28,800 - $122,999	30,000 Added 90.09%	63,300 $88,000
Q4 2022 Feb 14, 2023	SELL	$2.59 - $4.0 $90,650 - $140,000	-35,000 Reduced 51.24%	33,300 $124,000
Q3 2022 Nov 14, 2022	SELL	$5.78 - $9.32 $57,800 - $93,200	-10,000 Reduced 12.77%	68,300 $333,000
Q4 2021 Feb 14, 2022	BUY	$8.33 - $12.14 $652,239 - $950,562	78,300 New	78,300 $676,000

14.4K

Ticker IMPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,738,800
Market Cap $475K
Description
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is Trudhesa, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The c...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.